0.7331
price down icon0.88%   -0.0065
 
loading
전일 마감가:
$0.7396
열려 있는:
$0.74
하루 거래량:
275.12K
Relative Volume:
0.11
시가총액:
$11.89M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.1105
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
+0.29%
1개월 성능:
+0.42%
6개월 성능:
-76.12%
1년 성능:
-66.98%
1일 변동 폭
Value
$0.725
$0.743
1주일 범위
Value
$0.72
$0.77
52주 변동 폭
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
명칭
iBio Inc
Name
전화
302-355-0650
Name
주소
600 Madison Avenue, Suite 1601, New York, NY
Name
직원
54
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
IBIO's Discussions on Twitter

IBIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IBIO
iBio Inc
0.7331 12.00M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-28 개시 Chardan Capital Markets Buy
2021-11-29 개시 JMP Securities Mkt Outperform
2021-01-22 개시 Cantor Fitzgerald Overweight
2020-06-26 개시 Alliance Global Partners Buy

iBio Inc 주식(IBIO)의 최신 뉴스

pulisher
02:22 AM

What makes iBio Inc. stock price move sharplySmart Return Focused Trading - Metal.it

02:22 AM
pulisher
Jul 25, 2025

iBio Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about iBio Inc. stockFree Investment Timing Strategies - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives iBio Inc. stock priceSkyrocketing profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is iBio Inc. a good long term investmentExplosive earning power - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

how ibio stock performs during market volatilityFree Short-Term Stock Picks - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

what makes ibio inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying iBio Inc. stock nowFree Access to Investment Community - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why iBio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

How iBio Inc. stock performs during market volatilityFree Access to Investors Club - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

iBio (NYSEMKT:IBIO) Stock Price Down 0% – What’s Next? - Defense World

Jul 11, 2025
pulisher
Jun 25, 2025

iBio (IBIO) Receives Continued "Buy" Rating from Chardan Capital | IBIO Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results - Investing.com

Jun 24, 2025
pulisher
Jun 24, 2025

iBio Advances Obesity Care with Antibody Therapies - TipRanks

Jun 24, 2025
pulisher
Jun 24, 2025

iBio (IBIO) Reports Promising Preclinical Results in Obesity Stu - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results By Investing.com - Investing.com UK

Jun 24, 2025
pulisher
Jun 23, 2025

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agon - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

iBio's Next-Gen Obesity Therapies: A Strategic Pipeline with Transformative Potential - AInvest

Jun 23, 2025
pulisher
Jun 19, 2025

iBio Extends Promissory Note Maturity to 2026 - TipRanks

Jun 19, 2025
pulisher
Jun 17, 2025

Ibio nominates IBIO-610 as obesity development candidate - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

iBio (IBIO) Begins Preclinical Study of New Antibody Candidate | - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment | IBIO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates non-human primate study of IBIO-610 - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Breakthrough Obesity Drug Shows 77% Fat Reduction When Combined With GLP-1 Treatments - Stock Titan

Jun 16, 2025
pulisher
Jun 13, 2025

iBio (IBIO) Plans to Offer 11.25 Million Shares of Common Stock - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Sector Update: Health Care - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

IBio Files Prospectus for Resale of About 11.3 Million Shares - marketscreener.com

Jun 13, 2025
pulisher
Jun 10, 2025

Plant-Based Vaccines Market Future Business Opportunities 2025-2032 | Medicago, Inc., IBIO, Icon Genetics GmbH - newstrail.com

Jun 10, 2025
pulisher
May 29, 2025

iBio: University of Limerick programme to ‘shape the next generation’ of pharmaceutical manufacturing experts - University of Limerick

May 29, 2025

iBio Inc (IBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):